Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Immunohistochemical localization of the calcitonin gene-related peptide binding site in the primate trigeminovascular system using functional antagonist antibodies.

Neuroscience | 2016

Calcitonin gene-related peptide (CGRP) is a potent vasodilator and a neuromodulator implicated in the pathophysiology of migraine. It binds to the extracellular domains of calcitonin receptor-like receptor (CLR) and receptor activity-modifying protein (RAMP) 1 that together form the CGRP receptor. Antagonist antibodies against CGRP and its binding site at the receptor are clinically effective in preventing migraine attacks. The blood-brain barrier penetration of these antagonist antibodies is limited, suggesting that a potential peripheral site of action is sufficient to prevent migraine attacks. To further understand the sites of CGRP-mediated signaling in migraine, we used immunohistochemical staining with recently developed antagonist antibodies specifically recognizing a fusion protein of the extracellular domains of RAMP1 and CLR that comprise the CGRP binding pocket at the CGRP receptor in monkey and man. We confirmed binding of the antagonist antibodies to human vascular smooth muscle cells (VSMCs) of dural meningeal arteries and neurons in the trigeminal ganglion, both of which are likely sites of action for therapeutic antibodies in migraine patients. We further used one of these antibodies for detailed mapping on cynomolgus monkey tissue and found antagonist antibody binding sites at multiple levels in the trigeminovascular system: in the dura mater VSMCs, in neurons and satellite glial cells in the trigeminal ganglion, and in neurons in the spinal trigeminal nucleus caudalis. These data reinforce and clarify our understanding of CGRP receptor localization in a pattern consistent with a role for CGRP receptors in trigeminal sensitization and migraine pathology.

Pubmed ID: 27155150 RIS Download

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Mast Cell Tryptase (antibody)

RRID:AB_2206478

This monoclonal targets Mast cell tryptase isolated from human lung

View all literature mentions

PSD95 Antibody (antibody)

RRID:AB_10010580

This monoclonal targets PSD95

View all literature mentions

Monoclonal Anti-Actin, α-Smooth Muscle (antibody)

RRID:AB_476701

This monoclonal targets Actin, α-Smooth Muscle

View all literature mentions

Monoclonal Anti-Neurofilament 200 (Phos. and Non-Phos.) antibody produced in mouse (antibody)

RRID:AB_477257

This monoclonal targets Neurofilament 200 (Phos. and Non-Phos.) antibody produced in mouse

View all literature mentions

Monoclonal Anti-Calcitonin Gene-Related Peptide antibody produced in mouse (antibody)

RRID:AB_259000

This monoclonal targets Calcitonin Gene-Related Peptide antibody produced in mouse

View all literature mentions

PSD95 Antibody (antibody)

RRID:AB_10010580

This monoclonal targets PSD95

View all literature mentions

Mast Cell Tryptase (antibody)

RRID:AB_2206478

This monoclonal targets Mast cell tryptase isolated from human lung

View all literature mentions